Portfolio Holdings Detail for ISIN IE00B8FHGS14
Stock Name / FundiShares VI Public Limited Company - iShares Edge MSCI World Minimum Volatility UCITS ETF
IssuerBlackrock
Entity holding fund iShares VI Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300VML6THE3JJOS76
ETF TickerMINV(GBX) LSE
ETF TickerIQQ0(EUR) F
ETF TickerMINV.LS(GBX) CXE
ETF TickerMVOL.LS(USD) CXE
ETF TickerMVOL.MI(EUR) CXE
ETF TickerMVOLz(CHF) CXE
ETF TickerMVOL(EUR) ETF Plus
ETF TickerMINV.L(GBP) LSE

Holdings detail for VRTX

Stock NameVertex Pharmaceuticals Inc
TickerVRTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS92532F1003
LEI54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Buy at StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday. A number of other equities analysts have also weighed in on VRTX. HC Wainwright reiterated a “buy” rating and issued a $550.00 price target on shares of […] - 2025-03-13 06:26:55
Rep. Jefferson Shreve Purchases Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Representative Jefferson Shreve (R-Indiana) recently bought shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). In a filing disclosed on March 09th, the Representative disclosed that they had bought between $15,001 and $50,000 in Vertex Pharmaceuticals stock on February 24th. The trade occurred in the Representative’s “CRT – STANDARD UNIT TRUST” account. Representative Jefferson Shreve also recently made […] - 2025-03-12 06:04:59
IVW, AXP, FI, VRTX: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares S&P 500 Growth ETF (Symbol: IVW) where we have detected an approximate $306.8 million dollar outflow -- that's a 0.6% decrease week over - 2025-03-11 15:28:55
Company News for Mar 11, 2025
Companies in The News Are: VRTX, TSLA, NVDA, COIN - 2025-03-11 13:22:00
Nasdaq Correction: The 2 Smartest Stocks to Buy and Hold Forever
When you're on an airplane, the pilot or a flight attendant will typically announce over the loudspeaker to "buckle your seatbelt" when the air is turbulent. That could be good advice for investors right now, too. - 2025-03-11 09:31:00
Where Will Vertex Pharmaceuticals Be in 10 Years?
The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since gained the regulatory nod for four more and become the global leader in the CF market - 2025-03-11 08:25:00
5 Top Stocks to Buy in March
2025 has gotten off to a choppy start as some of the most valuable U.S.-based companies are dragging down the major stock market indexes. But getting caught up in short-term market movements is a mistake. - 2025-03-04 11:15:00
XLV, SYK, DHR, VRTX: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $434.3 million dollar outflow -- that's a 1.1% decrease - 2025-02-21 16:22:43
Vertex Pharmaceuticals (NASDAQ:VRTX) Lowered to Hold Rating by StockNews.com
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. VRTX has been the subject of a number of other reports. Scotiabank raised their price objective on Vertex Pharmaceuticals from $433.00 to $450.00 and gave the stock […] - 2025-02-21 06:55:07
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
Vertex Pharmaceuticals has lagged behind the broader market over the past year, and Wall Street analysts are cautiously optimistic about the stock’s future. - 2025-02-20 14:51:41
Blue Trust Inc. Sells 2,077 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Blue Trust Inc. lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 76.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 634 shares of the pharmaceutical company’s stock after selling 2,077 shares during the period. Blue […] - 2025-02-19 09:02:04
IUSG, ANET, VRTX, PH: ETF Outflow Alert
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Core S&P U.S. Growth ETF (Symbol: IUSG) where we have detected an approximate $324.0 million dollar outflow -- that's a 1.5% decrease we - 2025-02-13 15:47:21
Vertex Pharmaceuticals (NASDAQ:VRTX) Given “Hold” Rating at Needham & Company LLC
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report)‘s stock had its “hold” rating restated by research analysts at Needham & Company LLC in a research report issued on Tuesday,Benzinga reports. Other equities analysts have also issued reports about the stock. Citigroup started coverage on shares of Vertex Pharmaceuticals in a research report on Thursday, November 14th. […] - 2025-02-13 09:32:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Given New $467.00 Price Target at Barclays
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target hoisted by analysts at Barclays from $435.00 to $467.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “equal weight” rating on the pharmaceutical company’s stock. Barclays‘s price objective suggests a potential upside of 3.05% from […] - 2025-02-13 09:32:50
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $520.00
Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective upped by equities researchers at Truist Financial from $460.00 to $520.00 in a research report issued on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price target suggests a potential upside of 14.74% from the company’s […] - 2025-02-13 08:42:49
Fund Update: ALLIANCEBERNSTEIN L.P. Just Disclosed New Holdings
ALLIANCEBERNSTEIN L.P. just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-12 19:56:04
Vertex: Strong Sales, Stronger Pipeline
Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report.Key Metrics Metric Q4 2023 Q4 2024 Change vs. Expectations Revenue $2.52 billion $2.91 billion 16% Beat Earnings per share $3.71 $3.50 -6% Missed Trikafta/Kaftrio revenue $ - 2025-02-11 14:15:00
Fund Update: PARNASSUS INVESTMENTS, LLC Just Disclosed New Holdings
PARNASSUS INVESTMENTS, LLC just filed a portfolio update, which we received from a 13F disclosure. This disclosure reflects the funds' holdings for the 12-31-2024 report period. You can see the full portfolio on Quiver Quantitative, and track moves made by other funds. - 2025-02-10 15:42:57
Earnings Season Scorecard and Analyst Reports for Meta Platforms, Mastercard & Adobe
A real-time update on the Q4 earnings season is included in today's Research Daily, in addition to featuring updated analyst reports on Meta Platforms (META), Mastercard (MA), Adobe (ADBE) and others. - 2025-02-04 17:49:00
Schwab U.S. Large-Cap Growth ETF Experiences Big Inflow
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Schwab U.S. Large-Cap Growth ETF (Symbol: SCHG) where we have detected an approximate $315.4 million dollar inflow -- that's a 0.8% increase week ove - 2025-02-04 16:04:54
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 14:54:37
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 14:21:10
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 12:52:57
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 12:23:28
Scotiabank Issues Positive Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price hoisted by Scotiabank from $430.00 to $433.00 in a research note released on Friday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. Several other research analysts have also issued reports on VRTX. Morgan Stanley upped their target price […] - 2025-02-03 07:01:06
Vertex Pharmaceuticals (NASDAQ:VRTX) Receives “Overweight” Rating from Cantor Fitzgerald
Cantor Fitzgerald restated their overweight rating on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research report released on Friday,Benzinga reports. Cantor Fitzgerald currently has a $480.00 price target on the pharmaceutical company’s stock. VRTX has been the topic of a number of other reports. Wells Fargo & Company cut shares of Vertex […] - 2025-02-03 07:01:05
HC Wainwright Forecasts Strong Price Appreciation for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock
Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price lifted by HC Wainwright from $535.00 to $550.00 in a research report sent to investors on Friday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other analysts have also weighed in on VRTX. Citigroup began coverage on […] - 2025-02-03 07:01:05
Stocks Retreat on Tariff Anxiety
The S&P 500 Index ($SPX ) (SPY ) Friday closed down -0.50%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.14%. March E-mini S&P futures (ESH25 ) are down by -0.53%, and March E-mini Nasdaq... - 2025-02-03 06:11:06
Should You Pick VRTX Stock At $450?
Vertex Pharmaceuticals stock (NASDAQ: VRTX) is trending higher after the U.S. FDA approved Journavx – an oral non-opioid pain medication. This is a big win for Vertex, given that Journavx can potentially garner $4 billion in annual peak sales. For perspective, Vertex’ - 2025-02-03 03:17:52
Stocks Retreat in Afternoon Trading
This afternoon, the S&P 500 Index ($SPX ) (SPY ) is down -0.48%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.71%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up -0.36%. Stocks are moving lower this afternoon, after the Dow Jones Industrials posted an... - 2025-02-01 00:40:50

iShares VI Public Limited Company - iShares Edge MSCI World Minimum Volatility UCITS ETF VRTX holdings

DateNumber of VRTX Shares HeldBase Market Value of VRTX SharesLocal Market Value of VRTX SharesChange in VRTX Shares HeldChange in VRTX Base ValueCurrent Price per VRTX Share HeldPrevious Price per VRTX Share Held
2025-03-11 (Tuesday)44,853VRTX holding increased by 272USD 21,903,514VRTX holding decreased by -387432USD 21,903,514272USD -387,432 USD 488.34 USD 500.01
2025-03-10 (Monday)44,581VRTX holding decreased by -136USD 22,290,946VRTX holding increased by 456082USD 22,290,946-136USD 456,082 USD 500.01 USD 488.29
2025-03-07 (Friday)44,717VRTX holding increased by 2295USD 21,834,864VRTX holding increased by 978512USD 21,834,8642,295USD 978,512 USD 488.29 USD 491.64
2025-03-05 (Wednesday)42,422VRTX holding increased by 680USD 20,856,352VRTX holding increased by 560557USD 20,856,352680USD 560,557 USD 491.64 USD 486.22
2025-03-04 (Tuesday)41,742VRTX holding increased by 272USD 20,295,795VRTX holding increased by 252929USD 20,295,795272USD 252,929 USD 486.22 USD 483.31
2025-03-03 (Monday)41,470VRTX holding increased by 544USD 20,042,866VRTX holding increased by 406980USD 20,042,866544USD 406,980 USD 483.31 USD 479.79
2025-02-28 (Friday)40,926VRTX holding increased by 619USD 19,635,886VRTX holding increased by 510214USD 19,635,886619USD 510,214 USD 479.79 USD 474.5
2025-02-27 (Thursday)40,307VRTX holding increased by 134USD 19,125,672VRTX holding decreased by -121212USD 19,125,672134USD -121,212 USD 474.5 USD 479.1
2025-02-26 (Wednesday)40,173VRTX holding increased by 1072USD 19,246,884VRTX holding increased by 464719USD 19,246,8841,072USD 464,719 USD 479.1 USD 480.35
2025-02-25 (Tuesday)39,101VRTX holding increased by 268USD 18,782,165VRTX holding increased by 78251USD 18,782,165268USD 78,251 USD 480.35 USD 481.65
2025-02-24 (Monday)38,833USD 18,703,914VRTX holding decreased by -100578USD 18,703,9140USD -100,578 USD 481.65 USD 484.24
2025-02-21 (Friday)38,833USD 18,804,492VRTX holding increased by 151837USD 18,804,4920USD 151,837 USD 484.24 USD 480.33
2025-02-20 (Thursday)38,833VRTX holding increased by 402USD 18,652,655VRTX holding increased by 522446USD 18,652,655402USD 522,446 USD 480.33 USD 471.76
2025-02-19 (Wednesday)38,431USD 18,130,209VRTX holding increased by 370860USD 18,130,2090USD 370,860 USD 471.76 USD 462.11
2025-02-18 (Tuesday)38,431USD 17,759,349VRTX holding increased by 119520USD 17,759,3490USD 119,520 USD 462.11 USD 459
2025-02-17 (Monday)38,431USD 17,639,829USD 17,639,8290USD 0 USD 459 USD 459
2025-02-14 (Friday)38,431USD 17,639,829VRTX holding decreased by -137583USD 17,639,8290USD -137,583 USD 459 USD 462.58
2025-02-13 (Thursday)38,431USD 17,777,412VRTX holding increased by 360483USD 17,777,4120USD 360,483 USD 462.58 USD 453.2
2025-02-12 (Wednesday)38,431USD 17,416,929VRTX holding decreased by -77631USD 17,416,9290USD -77,631 USD 453.2 USD 455.22
2025-02-11 (Tuesday)38,431USD 17,494,560VRTX holding decreased by -566857USD 17,494,5600USD -566,857 USD 455.22 USD 469.97
2025-02-10 (Monday)38,431USD 18,061,417VRTX holding increased by 24980USD 18,061,4170USD 24,980 USD 469.97 USD 469.32
2025-02-07 (Friday)38,431USD 18,036,437VRTX holding decreased by -455023USD 18,036,4370USD -455,023 USD 469.32 USD 481.16
2025-02-06 (Thursday)38,431USD 18,491,460VRTX holding decreased by -279778USD 18,491,4600USD -279,778 USD 481.16 USD 488.44
2025-02-05 (Wednesday)38,431VRTX holding increased by 134USD 18,771,238VRTX holding increased by 301361USD 18,771,238134USD 301,361 USD 488.44 USD 482.28
2025-02-04 (Tuesday)38,297VRTX holding increased by 134USD 18,469,877VRTX holding increased by 519147USD 18,469,877134USD 519,147 USD 482.28 USD 470.37
2025-02-03 (Monday)38,163USD 17,950,730VRTX holding increased by 331636USD 17,950,7300USD 331,636 USD 470.37 USD 461.68
2025-01-31 (Friday)38,163VRTX holding decreased by -134USD 17,619,094VRTX holding increased by 829689USD 17,619,094-134USD 829,689 USD 461.68 USD 438.4
2025-01-30 (Thursday)38,297VRTX holding increased by 134USD 16,789,405VRTX holding decreased by -60323USD 16,789,405134USD -60,323 USD 438.4 USD 441.52
2025-01-29 (Wednesday)38,163VRTX holding decreased by -134USD 16,849,728VRTX holding decreased by -26994USD 16,849,728-134USD -26,994 USD 441.52 USD 440.68
2025-01-28 (Tuesday)38,297VRTX holding increased by 268USD 16,876,722VRTX holding decreased by -3591USD 16,876,722268USD -3,591 USD 440.68 USD 443.88
2025-01-27 (Monday)38,029VRTX holding decreased by -134USD 16,880,313VRTX holding increased by 103095USD 16,880,313-134USD 103,095 USD 443.88 USD 439.62
2025-01-24 (Friday)38,163USD 16,777,218VRTX holding decreased by -4198USD 16,777,2180USD -4,198 USD 439.62 USD 439.73
2025-01-23 (Thursday)38,163USD 16,781,416VRTX holding increased by 447652USD 16,781,4160USD 447,652 USD 439.73 USD 428
2025-01-22 (Wednesday)38,163USD 16,333,764VRTX holding increased by 4198USD 16,333,7640USD 4,198 USD 428 USD 427.89
2025-01-21 (Tuesday)38,163USD 16,329,566USD 16,329,566
2025-01-20 (Monday)38,163USD 16,104,786USD 16,104,786
2025-01-17 (Friday)38,163USD 16,104,786USD 16,104,786
2025-01-16 (Thursday)38,163USD 15,912,444USD 15,912,444
2025-01-15 (Wednesday)38,163USD 16,191,034USD 16,191,034
2025-01-14 (Tuesday)38,163USD 15,710,181USD 15,710,181
2025-01-13 (Monday)38,163USD 15,775,439USD 15,775,439
2025-01-10 (Friday)38,163USD 15,630,038USD 15,630,038
2025-01-09 (Thursday)36,287USD 14,954,236USD 14,954,236
2025-01-09 (Thursday)36,287USD 14,954,236USD 14,954,236
2025-01-09 (Thursday)36,287USD 14,954,236USD 14,954,236
2025-01-08 (Wednesday)36,287USD 14,954,236USD 14,954,236
2025-01-08 (Wednesday)36,287USD 14,954,236USD 14,954,236
2025-01-08 (Wednesday)36,287USD 14,954,236USD 14,954,236
2025-01-02 (Thursday)34,943USD 14,178,472USD 14,178,472
2024-12-30 (Monday)34,943USD 13,954,487USD 13,954,487
2024-12-24 (Tuesday)34,943USD 14,263,034USD 14,263,034
2024-12-23 (Monday)34,943USD 14,161,350USD 14,161,350
2024-12-20 (Friday)34,943USD 13,881,806USD 13,881,806
2024-12-19 (Thursday)34,943USD 13,859,792USD 13,859,792
2024-12-18 (Wednesday)34,943USD 15,636,993USD 15,636,993
2024-12-10 (Tuesday)35,213VRTX holding decreased by -135USD 16,522,644VRTX holding decreased by -231601USD 16,522,644-135USD -231,601 USD 469.22 USD 473.98
2024-12-09 (Monday)35,348USD 16,754,245VRTX holding increased by 419934USD 16,754,2450USD 419,934 USD 473.98 USD 462.1
2024-12-06 (Friday)35,348USD 16,334,311VRTX holding increased by 77059USD 16,334,3110USD 77,059 USD 462.1 USD 459.92
2024-12-05 (Thursday)35,348USD 16,257,252VRTX holding decreased by -143513USD 16,257,2520USD -143,513 USD 459.92 USD 463.98
2024-12-04 (Wednesday)35,348USD 16,400,765VRTX holding increased by 247789USD 16,400,7650USD 247,789 USD 463.98 USD 456.97
2024-12-03 (Tuesday)35,348VRTX holding decreased by -270USD 16,152,976VRTX holding decreased by -435395USD 16,152,976-270USD -435,395 USD 456.97 USD 465.73
2024-12-02 (Monday)35,618USD 16,588,371VRTX holding decreased by -85483USD 16,588,3710USD -85,483 USD 465.73 USD 468.13
2024-11-29 (Friday)35,618VRTX holding decreased by -134USD 16,673,854VRTX holding increased by 64905USD 16,673,854-134USD 64,905 USD 468.13 USD 464.56
2024-11-28 (Thursday)35,752USD 16,608,949USD 16,608,9490USD 0 USD 464.56 USD 464.56
2024-11-27 (Wednesday)35,752USD 16,608,949VRTX holding decreased by -89738USD 16,608,9490USD -89,738 USD 464.56 USD 467.07
2024-11-26 (Tuesday)35,752USD 16,698,687VRTX holding increased by 191631USD 16,698,6870USD 191,631 USD 467.07 USD 461.71
2024-11-25 (Monday)35,752VRTX holding decreased by -12483USD 16,507,056VRTX holding decreased by -5245482USD 16,507,056-12,483USD -5,245,482 USD 461.71 USD 450.97
2024-11-22 (Friday)48,235VRTX holding decreased by -543USD 21,752,538VRTX holding decreased by -215610USD 21,752,538-543USD -215,610 USD 450.97 USD 450.37
2024-11-21 (Thursday)48,778USD 21,968,148VRTX holding decreased by -41949USD 21,968,1480USD -41,949 USD 450.37 USD 451.23
2024-11-20 (Wednesday)48,778USD 22,010,097VRTX holding increased by 157065USD 22,010,0970USD 157,065 USD 451.23 USD 448.01
2024-11-19 (Tuesday)48,778USD 21,853,032VRTX holding decreased by -926782USD 21,853,0320USD -926,782 USD 448.01 USD 467.01
2024-11-18 (Monday)48,778USD 22,779,814VRTX holding decreased by -1121406USD 22,779,8140USD -1,121,406 USD 467.01 USD 490
2024-11-12 (Tuesday)48,778USD 23,901,220VRTX holding decreased by -571678USD 23,901,2200USD -571,678 USD 490 USD 501.72
2024-11-11 (Monday)48,778USD 24,472,898USD 24,472,8980USD 0 USD 501.72 USD 501.72
2024-11-11 (Monday)48,778USD 24,472,898USD 24,472,8980USD 0 USD 501.72 USD 501.72
2024-11-08 (Friday)49,140USD 25,392,604VRTX holding increased by 702211USD 25,392,6040USD 702,211 USD 516.74 USD 502.45
2024-11-07 (Thursday)49,140USD 24,690,393VRTX holding increased by 432923USD 24,690,3930USD 432,923 USD 502.45 USD 493.64
2024-11-06 (Wednesday)49,140USD 24,257,470VRTX holding decreased by -306633USD 24,257,4700USD -306,633 USD 493.64 USD 499.88
2024-11-05 (Tuesday)49,140VRTX holding decreased by -1448USD 24,564,103VRTX holding increased by 646097USD 24,564,103-1,448USD 646,097 USD 499.88 USD 472.8
2024-11-04 (Monday)50,588USD 23,918,006VRTX holding increased by 84987USD 23,918,0060USD 84,987 USD 472.8 USD 471.12
2024-11-01 (Friday)50,588USD 23,833,019VRTX holding decreased by -245857USD 23,833,0190USD -245,857 USD 471.12 USD 475.98
2024-10-31 (Thursday)50,588USD 24,078,876VRTX holding increased by 45529USD 24,078,8760USD 45,529 USD 475.98 USD 475.08
2024-10-30 (Wednesday)50,588USD 24,033,347VRTX holding increased by 238775USD 24,033,3470USD 238,775 USD 475.08 USD 470.36
2024-10-29 (Tuesday)50,588VRTX holding increased by 181USD 23,794,572VRTX holding decreased by -217811USD 23,794,572181USD -217,811 USD 470.36 USD 476.37
2024-10-28 (Monday)50,407USD 24,012,383VRTX holding decreased by -67041USD 24,012,3830USD -67,041 USD 476.37 USD 477.7
2024-10-25 (Friday)50,407USD 24,079,424VRTX holding increased by 291857USD 24,079,4240USD 291,857 USD 477.7 USD 471.91
2024-10-24 (Thursday)50,407VRTX holding increased by 181USD 23,787,567VRTX holding increased by 178836USD 23,787,567181USD 178,836 USD 471.91 USD 470.05
2024-10-23 (Wednesday)50,226USD 23,608,731VRTX holding decreased by -244099USD 23,608,7310USD -244,099 USD 470.05 USD 474.91
2024-10-22 (Tuesday)50,226USD 23,852,830VRTX holding decreased by -159718USD 23,852,8300USD -159,718 USD 474.91 USD 478.09
2024-10-21 (Monday)50,226USD 24,012,548VRTX holding decreased by -246610USD 24,012,5480USD -246,610 USD 478.09 USD 483
2024-10-18 (Friday)50,226USD 24,259,158USD 24,259,158
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00B8FHGS14

Show aggregate share trades of VRTX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-03-11BUY272 488.340* 470.02
2025-03-10SELL-136 500.010* 469.57 Profit of 63,862 on sale
2025-03-07BUY2,295 488.290* 469.28
2025-03-05BUY680 491.640* 468.93
2025-03-04BUY272 486.220* 468.66
2025-03-03BUY544 483.310* 468.42
2025-02-28BUY619 479.790* 468.24
2025-02-27BUY134 474.500* 468.13
2025-02-26BUY1,072 479.100* 467.95
2025-02-25BUY268 480.350* 467.73
2025-02-20BUY402 480.330* 466.95
2025-02-05BUY134 488.440* 467.06
2025-02-04BUY134 482.280* 466.70
2025-01-31SELL-134 461.680* 466.74 Profit of 62,543 on sale
2025-01-30BUY134 438.400* 467.44
2025-01-29SELL-134 441.520* 468.11 Profit of 62,727 on sale
2025-01-28BUY268 440.680* 468.83
2025-01-27SELL-134 443.880* 469.50 Profit of 62,914 on sale
2024-12-10SELL-135 469.220* 472.58 Profit of 63,798 on sale
2024-12-03SELL-270 456.970* 474.22 Profit of 128,039 on sale
2024-11-29SELL-134 468.130* 474.78 Profit of 63,621 on sale
2024-11-25SELL-12,483 461.710* 476.65 Profit of 5,950,073 on sale
2024-11-22SELL-543 450.970* 477.88 Profit of 259,487 on sale
2024-11-05SELL-1,448 499.880* 474.03 Profit of 686,401 on sale
2024-10-29BUY181 470.360* 474.84
2024-10-24BUY181 471.910* 474.35
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-03-12332,397653481,02169.1%
2025-03-11273,529437501,40954.6%
2025-03-10342,82352597,06757.4%
2025-03-07231,760226414,25555.9%
2025-03-06333,034102506,67265.7%
2025-03-05211,79523333,31363.5%
2025-03-04269,76434456,50559.1%
2025-03-03264,333109460,34757.4%
2025-02-28290,679561483,11260.2%
2025-02-27163,115716318,29751.2%
2025-02-26147,097945243,99860.3%
2025-02-25198,750113440,22045.1%
2025-02-24194,2909399,05648.7%
2025-02-21278,90716442,43663.0%
2025-02-20307,3420562,72954.6%
2025-02-19196,482807643,48430.5%
2025-02-18241,4326,621515,10946.9%
2025-02-14218,39658385,39856.7%
2025-02-13330,30769540,75161.1%
2025-02-12253,056586490,79051.6%
2025-02-11454,2461,902682,70666.5%
2025-02-10384,962106626,41361.5%
2025-02-07311,677511469,67766.4%
2025-02-06241,3734406,94159.3%
2025-02-05412,75666655,66563.0%
2025-02-04599,47243792,18975.7%
2025-02-03617,143398887,62269.5%
2025-01-311,191,3076371,734,41268.7%
2025-01-30261,23145462,12656.5%
2025-01-29207,10685460,01445.0%
2025-01-28300,3429430,70769.7%
2025-01-27345,21857512,56567.4%
2025-01-24400,74018682,55158.7%
2025-01-23488,926117635,94676.9%
2025-01-22209,467283402,08252.1%
2025-01-21359,6985,293550,66165.3%
2025-01-17347,33310536,60764.7%
2025-01-16323,363635500,29864.6%
2025-01-15285,9852,042463,10061.8%
2025-01-14273,399656557,39349.0%
2025-01-13344,521161709,60948.6%
2025-01-10404,383363670,27860.3%
2025-01-08230,17976441,78052.1%
2025-01-07259,653805673,98138.5%
2025-01-06257,038214745,81534.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.